医学博士，留学归国人员。2010年赴奥地利萨尔兹堡Paracelsus医科大学附属医院学习心血管影像技术。2014年赴美国纽约州立卫生部Wadsworth中心转化医学部从事与心律失常相关钙离子通道的基础研究。已发表学术论文20余篇，参与编著专业书刊3部。
代表文章：
1.Li Y, Tao L, Xu Y, Guo R. Taxifolin ameliorates abdominal aortic aneurysm by preventing inflammation and apoptosis and extracellular matrix degradation via inactivating TLR4/NF-κB axis. Int Immunopharmacol. 2023 Jun;119:110197. （唯一通讯）
2.Shen R, Zhang P, Liu J, Guo R, Xu Y. Five-Year Clinical Outcomes After XIENCE PRIME Everolimus Elution Coronary Stent System (EECSS) Implantation. CVIA. 2023. 8(1). 999. （唯一通讯）
3.Shen R, Zhang P, Guo R, Xu Y. Serum visfatin concentrations are positively associated with ventricular arrhythmias: a single-center preliminary study. Turk J Med Sci. 2022 Oct;52(5):1523-1531. （唯一通讯）
4.Ni J, Li Y, Xu Y, Guo R. Salidroside protects against cardiomyocyte apoptosis and ventricular remodeling by AKT/HO-1 signaling pathways in a diabetic cardiomyopathy mouse model. Phytomedicine. 2021 Feb;82:153406. （唯一通讯）
5.Ni J, Li Y, Li W, Guo R. Salidroside protects against foam cell formation and apoptosis, possibly via the MAPK and AKT signaling pathways. Lipids Health Dis. 2017;16(1):198;
6.Guo R, Liu W, Liu B, Zhang B, Li W, Xu Y. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism. Int J Cardiol. 2015;191:36-45;
7.Guo R, Liu B, Wang K, Zhou S, Li W, Xu Y. Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway. Diab Vasc Dis Res. 2014;11(2):92-102.
主持课题：
1.国家自然基金青年项目（81700378）：基质金属蛋白酶-28（MMP-28/Epilysin）调控巨噬细胞极化及抑制动脉粥样硬化形成机制的研究;
2.同济大学青年优秀人才培养行动计划（1700014）：红景天苷抑制动脉粥样硬化斑块内泡沫细胞形成和凋亡的分子机制;
3.2024年杨浦区卫健委课题面上项目（YPM202415）：肺静脉前庭扩大冷冻消融治疗阵发性心房颤动的有效性和安全性的临床研究
客座编辑：
1.Cardiology Research and Practice杂志，房颤治疗特刊（Atrial Fibrillation Treatment in the Interventional Therapy Era），Lead Guest Editor
